نتایج جستجو برای: nccn guidelines

تعداد نتایج: 143623  

2013

Assumptions Appropriate mammographic screening per NCCN, ACS, USPSTF and UMHS screening guidelines. Generally mammogram is not indicated for women age <30 because of low sensitivity and specificity. “Diagnostic breast imaging” refers to diagnostic mammogram and/or ultrasound. At most ages the combination of both imaging techniques yields the most accurate results and is recommended based on pat...

2014
Matthew Bernetich Caspian Oliai Rachelle Lanciano Alexandra Hanlon John Lamond Stephen Arrigo Jun Yang Michael Good Jing Feng Royce Brown Bruce Garber Michael Mooreville Luther W. Brady

PURPOSE To report an update of our previous experience using stereotactic body radiation therapy (SBRT) for the primary treatment of prostate cancer, risk stratified by the updated National Comprehensive Cancer Network (NCCN) version 2.2014, reporting efficacy and toxicity in a community hospital setting. METHODS From 2007 to 2012, 142 localized prostate cancer patients were treated with SBRT...

2011
C Vidall P Dielenseger C Farrell E Lennan P Muxagata P Fernández-Ortega K Paradies

Chemotherapy-induced nausea and vomiting (CINV) is a common, but now often overlooked side effect of cancer treatment, and one that can be largely prevented through the implementation of international evidence-based guidelines. The European CINV Forum, comprising nurses from France, Germany, Portugal, Spain and the UK, discussed the use of CINV preventive strategies in routine practice, and the...

Journal: :Journal of the National Comprehensive Cancer Network : JNCCN 2011
Peter L Greenberg Eyal Attar John M Bennett Clara D Bloomfield Carlos M De Castro H Joachim Deeg James M Foran Karin Gaensler Guillermo Garcia-Manero Steven D Gore David Head Rami Komrokji Lori J Maness Michael Millenson Stephen D Nimer Margaret R O'Donnell Mark A Schroeder Paul J Shami Richard M Stone James E Thompson Peter Westervelt

These suggested practice guidelines are based on extensive evaluation of the reviewed risk-based data and indicate useful current approaches for managing patients with MDS. Four drugs have recently been approved by the FDA for treating specific subtypes of MDS: lenalidomide for MDS patients with del(5q) cytogenetic abnormalities; azacytidine and decitabine for treating patients with higher-risk...

2010
Andrew D. Zelenetz Jeremy S. Abramson Ranjana H. Advani Myron S. Czuczman Luis E. Fayad Rachel Rabinovitch Nishitha Reddy Lode J. Swinnen Nadeem Zafar Ayman A. Saad Nancy Lee Harris Steven M. Horwitz Youn H. Kim

Journal: :Egyptian Journal of Hematology and Bone Marrow Transplantation 2017

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید